Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Breast Cancer Research and Treatment
|
February 24, 2001
Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte contre le Cancer (FNCLCC)
A Laplanche, L Alzieu, T Delozier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy
G Freyer, T Delozier, M Lichinister, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
R Arriagada, M Spielmann, S Koscielny, et al.
Oncology
|
April 22, 2008
Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients
J E Kurtz, F Rousseau, N Meyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2005
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
R Arriagada, M G Lê, M Spielmann, et al.
British Journal of Cancer
|
June 2, 2005
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
D Serin, M Verrill, A Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Pirarubicin in advanced breast cancer: a French cooperative phase II study
M Spielmann, P Kerbrat, T Delozier, et al.
Breast Cancer Research and Treatment
|
January 1, 1986
Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial
T Delozier, J P Julien, P Juret, et al.
Presse Medicale (Paris, France : 1983)
|
June 4, 1983
[Reliability of cytologic puncture. Who should perform the puncture of breast tumors?]
E de Ranieri, A M Mandard, P Juret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
G Macquart-Moulin, P Viens, T Palangié, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Breast Cancer Research and Treatment
|
February 24, 2001
Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte contre le Cancer (FNCLCC)
A Laplanche, L Alzieu, T Delozier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy
G Freyer, T Delozier, M Lichinister, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
R Arriagada, M Spielmann, S Koscielny, et al.
Oncology
|
April 22, 2008
Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients
J E Kurtz, F Rousseau, N Meyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2005
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
R Arriagada, M G Lê, M Spielmann, et al.
British Journal of Cancer
|
June 2, 2005
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
D Serin, M Verrill, A Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Pirarubicin in advanced breast cancer: a French cooperative phase II study
M Spielmann, P Kerbrat, T Delozier, et al.
Breast Cancer Research and Treatment
|
January 1, 1986
Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial
T Delozier, J P Julien, P Juret, et al.
Presse Medicale (Paris, France : 1983)
|
June 4, 1983
[Reliability of cytologic puncture. Who should perform the puncture of breast tumors?]
E de Ranieri, A M Mandard, P Juret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
G Macquart-Moulin, P Viens, T Palangié, et al.
Page
of 5